 at 5 years; and (6) cost of the procedure. The
guideline committee and the systematic review did not
include a formal cost-effectiveness analysis because
almost all reported and reviewed studies had been performed in the United Kingdom and other European countries, where the cost and reimbursement system differs
from that in the United States.19 Therefore, the costeffectiveness judgments in the evidence to decision tables were usually labeled as unknown.
Evidence synthesis. The guideline panel for the present
document